Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 29, 2021

View Archived Issues

Surface Ophthalmics initiates phase II study of SURF-100 for chronic dry eye disease

Gray matter damage in MS starts at synapses

Few-shot learning enhances biomarker identification

CARB-X funding supports Lumen's development of immunotherapy to prevent diarrheal diseases

Contradictory results for FCGR2C gene allele regarding HIV-1 infection risk

PHA-121 demonstrates promising safety and PK profile in phase I study

Final analysis data presented from BLAZE-1 phase II/III study in mild-to-moderate COVID-19

BREEZE study of Tyvaso DPI dry powder formulation meets primary endpoint

PRV-3279 prevents immunogenicity in a preclinical model of gene therapy for Pompe disease

Tempol decreases cytokines from stimulated cells from patients with COVID-19

Sunshine Lake Pharma patents SGLT-1 inhibitors

EyePoint initiates phase I study of EYP-1901 for the treatment of wet AMD

ChemoCentryx synthesizes new PD-1/PD-L1 interaction inhibitors

Positive GLP toxicology study results presented for CBX-12

APX-005M regimen is active and tolerable in metastatic pancreatic adenocarcinoma trial

Idorsia Pharmaceuticals presents IDO1 and TDO inhibitors

FDA clears IND application for PBFT-02 gene therapy candidate

Sapience Therapeutics divulges BCL9 mimetic peptides for cancer

FDA approves IND application for Zofin in COPD

Progen patents new fusion proteins for allergic diseases

PF-06826647 is safe and significantly improves disease activity in subjects with plaque psoriasis

Novavax reports phase III data from U.K. trial of COVID-19 vaccine NVX-CoV2373

FDA lifts clinical hold on phase I/II trial of BPX-601

Kintor cleared to begin Brazilian trial of proxalutamide for hospitalized COVID-19 patients

Reduced TBX15 expression is a prognostic marker in patients with HCC

Macrophages key to liver cells relaxin'

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...